表观遗传学视角下的室管膜瘤:综述
本文综述室管膜瘤的遗传与表观遗传学基础,指出基于DNA甲基化和基因表达谱已将其分为至少九个分子亚型,DNA甲基化成为与组织病理学并行的分类工具,大型回顾性队列显示分子亚型身份是预后的独立预测因素,但前瞻性试验数据有限。
要点
- 室管膜瘤基于DNA甲基化和基因表达谱可分为至少九个分子亚型。
- DNA甲基化已成为脑肿瘤分类的有效工具,与组织病理学并用。
- 分子亚型身份在回顾性队列中是预后的强大独立预测因素。
核心结论
- 表观遗传改变在室管膜瘤分子分类中起核心作用,并可能揭示治疗机会。
研究设计与样本
- 综述已发表的室管膜瘤遗传与表观遗传学文献,并汇总可能指向治疗策略的遗传驱动信息。
主要发现
- 室管膜瘤是分子异质性疾病,基于DNA甲基化和基因表达谱已分为至少九个不同分子亚型。
- DNA甲基化已成为脑肿瘤分类的有效工具,与组织病理学及其他分子诊断并用。
- 大型回顾性队列描述分子亚型身份是预后的强大独立预测因素。
- 目前前瞻性试验的已发表数据有限,但即将出现,将推动下一代临床研究中的分子分层。
临床怎么用
- 可将DNA甲基化分类与组织病理学结合用于室管膜瘤的分子分型。
- 分子亚型身份可作为预后评估的参考因素。
局限性
- 目前前瞻性试验的已发表数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Ependymoma is the third most common malignant pediatric brain tumor. Although the biology that drives ependymoma is slowly being unraveled, the ability to translate these findings to clinical care remains an ongoing challenge. Epigenetic alterations appear to play a central role in the development of molecular classification of ependymoma. METHODS: We reviewed the published literature available describing genetic and epigenetic underpinnings of ependymoma that have been reported to date and have summarized the information regarding genetic drivers of ependymoma that may point us toward therapeutic strategies. RESULTS: Ependymoma is a molecularly heterogeneous disease which has now been divided into at least nine distinct molecular subtypes based on DNA methylation and gene expression profiling. DNA methylation has emerged as an effective tool for classification of brain tumors alongside histopathology and other molecular diagnostics. There have been large retrospective cohorts describing molecular subgroup identity as a powerful independent predictor of outcome. There is limited published data on prospective trials to date however this is forthcoming which will lead to molecular stratification in the next generation of clinical studies. CONCLUSION: This is a review of recent advancements in our understanding of the epigenetic basis of ependymoma and discussion of how these findings reveal potential therapeutic opportunities.
引用
- Stuckert A, Bertrand KC, Wang P, et al. Weighing ependymoma as an epigenetic disease. J Neurooncol. 2020. PMID: 32964355. doi:10.1007/s11060-020-03562-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。